在COVID-19之前和之后的登革热中血液静止的差异概况
Alanna Calheiros Santos1, Julya Farias Carneiro1, Anna Paula de Souza E Silva Sales2
1Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil.
Viruses
|November 27, 2025
概括
之前的COVID-19暴露可能会改变登革热.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 登革热和COVID-19是导致凝血病的病毒性疾病.
- SARS-CoV-2和登革热病毒 (DENV) 抗体之间的交叉反应是可能的.
- 之前的COVID-19感染可能会影响登革热免疫病原发生.
研究的目的:
- 为了研究之前的COVID-19暴露对登革热的静血参数的影响.
- 分析促凝剂,抗凝剂和纤维溶解媒介的变化.
- 为了评估体外血小板激活.
主要方法:
- 在COVID-19大流行之前和之后,在登革热患者中量化了等离子体介质 (亚酸盐,凝血因子).
- 在实验室中使用DENV-2进行了血小板激活测试.
- 血静参数和出血表现在COVID-19前后的登革热队列之间进行了比较.
主要成果:
- 后COVID-19登革热患者表现出增加的组织因子 (TF) 和高酸盐,特别是在没有出血的情况下.
- 在COVID-19前,登革热的出血事件更频繁,XIII因子,抗血和等离子素水平更高.
- 实验室研究表明,DENV-2感染的血小板暴露在登革热患者的血中减少了酸盐的产生.
结论:
- 以前的COVID-19暴露似乎调节了登革热的静血反应.
- 这些变化可能会影响登革热病理病理学.
- 研究结果表明,登革热管理的新研究和治疗策略.
更多相关视频
07:06A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
9.1K
06:00Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
2.0K
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Introduction to Hemostasis
13.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.1K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
